<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Trials</journal-id><journal-id journal-id-type="iso-abbrev">Trials</journal-id><journal-title-group><journal-title>Trials</journal-title></journal-title-group><issn pub-type="epub">1745-6215</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28031038</article-id><article-id pub-id-type="pmc">5192581</article-id><article-id pub-id-type="publisher-id">1740</article-id><article-id pub-id-type="doi">10.1186/s13063-016-1740-3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Using a smartphone app to reduce cognitive vulnerability and mild depressive symptoms: Study protocol of an exploratory randomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1260-6830</contrib-id><name><surname>Giosan</surname><given-names>Cezar</given-names></name><address><email>giosan@outlook.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Mogoa&#x0015f;e</surname><given-names>Cristina</given-names></name><address><email>cristina.mogoase@ubbcluj.ro</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Cobeanu</surname><given-names>Oana</given-names></name><address><email>oana.cobeanu@ubbcluj.ro</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Szent&#x000e1;gotai T&#x00103;tar</surname><given-names>Aurora</given-names></name><address><email>auraszentagotai@psychology.ro</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Mure&#x0015f;an</surname><given-names>Vlad</given-names></name><address><email>contact@muresanvlad.ro</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Boian</surname><given-names>Rare&#x00219;</given-names></name><address><email>rares.boian@ubbcluj.ro</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label>Department of Clinical Psychology and Psychotherapy, Babe&#x00219;-Bolyai University, Cluj-Napoca, Romania </aff><aff id="Aff2"><label>2</label>Berkeley College, New York, NY USA </aff><aff id="Aff3"><label>3</label>Department of Psychology, University of Bucharest, Bucharest, Romania </aff></contrib-group><pub-date pub-type="epub"><day>28</day><month>12</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>28</day><month>12</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>17</volume><elocation-id>609</elocation-id><history><date date-type="received"><day>7</day><month>6</month><year>2016</year></date><date date-type="accepted"><day>4</day><month>12</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2016</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>Depression is a major challenge worldwide, with significant increasing personal, economic, and societal costs. Although empirically supported treatments have been developed, they are not always available for patients in routine clinical care. Therefore, we need effective and widely accessible strategies to prevent the onset of the very first depressive symptoms. Mental health apps could prove a valuable solution for this desideratum. Although preliminary research has indicated that such apps can be useful in treating depression, no study has attempted to test their utility in preventing depressive symptoms. The aim of this exploratory study is to contrast the efficacy of a smartphone app in reducing cognitive vulnerability and mild depressive symptoms, as risk factors for the onset of depression, against a wait-list condition. More specifically, we aim to test an app designed to (1) decrease general cognitive vulnerability and (2) promote engagement in protective, adaptive activities, while (3) counteracting (through gamification and customization) the tendency of premature dropout from intervention.</p></sec><sec><title>Methods/design</title><p>Romanian-speaking adults (18&#x000a0;years and older) with access to a computer and the Internet and who own a smartphone are included in the study. Two parallel randomized clinical trials are conducted: in the first one, 50 participants free of depressive symptoms (i.e., who obtain scores &#x02264;4 on the Patient Health Questionnaire, PHQ-9) will be included, while in the second one 50 participants with minimal depressive symptoms (i.e., who obtain PHQ-9 scores between 5 and 9) will be included. Participants undergoing therapy, presenting with substance abuse problems, psychotic symptoms, and organic brain disorders, or serious legal or health issues that would prevent them from using the app, as well as participants reporting suicidal ideation are excluded. Participants randomized to the active intervention will autonomously use the smartphone app for 4&#x000a0;weeks, while the others will be given access to the app after 4&#x000a0;weeks from randomization. The primary outcomes are (1) cognitive vulnerability factors as defined within the cognitive behavioral therapy (CBT) paradigm (i.e., dysfunctional cognitions, irrational beliefs, and negative automatic thoughts) (for the first trial), and (2) level of depressive symptomatology (for the second trial). The app includes self-help materials and exercises based on CBT for depression, presented in a tailored manner and incorporating gamification elements aimed at boosting motivation to use the app.</p></sec><sec><title>Discussion</title><p>This study protocol is the first to capitalize on the ubiquity of smartphones to large-scale dissemination of CBT-based strategies aimed at preventing depression in non-clinical populations.</p></sec><sec><title>Trial registration</title><p>ClinicalTrials.gov: <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT02783118">NCT02783118</ext-link>. Registered on 26 May 2016.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1186/s13063-016-1740-3) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Depression</kwd><kwd>Prevention</kwd><kwd>Protocol</kwd><kwd>Randomized trial</kwd><kwd>CBT</kwd><kwd>Smartphone app</kwd></kwd-group><funding-group><award-group><funding-source><institution>EEA Financial Mechanism 2009 - 2014</institution></funding-source><award-id>EEA-JRP-RO-NO-2013-1-0358</award-id><principal-award-recipient><name><surname>Giosan</surname><given-names>Cezar</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p>About 350 million people of all ages are affected by depression worldwide [<xref ref-type="bibr" rid="CR1">1</xref>]. In 2008, the World Health Organization (WHO) estimated depression to be the third largest contributor to the global disease burden (GDB) globally and the number one contributor to disease burden in developed countries [<xref ref-type="bibr" rid="CR2">2</xref>]. In 2010, depression was estimated to be the second largest contributor to GDB [<xref ref-type="bibr" rid="CR3">3</xref>] and, by 2030, it is expected to become its leading contributor [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p>In the USA alone, depression costs $81 billion [<xref ref-type="bibr" rid="CR5">5</xref>], while in Europe it reaches about &#x020ac;118 billion per year [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>].</p><p>Although effective treatments for this condition do exist [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>], they do not seem to help in decreasing the prevalence of depression or the associated GDB [<xref ref-type="bibr" rid="CR10">10</xref>&#x02013;<xref ref-type="bibr" rid="CR12">12</xref>]. One of the most important factors contributing to this reality is the fact that fewer than half of those in need of treatment (and in many countries, fewer than 10%) receive adequate care [<xref ref-type="bibr" rid="CR1">1</xref>]. Some reasons for this are the limited availability of adequately trained therapists, stigma, or logistical costs [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Thus, increasing treatment accessibility for the affected people can have the potential to reduce the GDB associated with depression.</p><p>Besides increasing the treatment availability for people experiencing depression, it is also very important to <italic>prevent</italic> the development of depressive symptoms. Subthreshold depression has been shown to predict the onset of full-blown depressive episodes [<xref ref-type="bibr" rid="CR15">15</xref>]. In addition, research shows that about 80% of people who suffer a first major depressive episode will have at least one more [<xref ref-type="bibr" rid="CR16">16</xref>], with a lifetime average of four episodes [<xref ref-type="bibr" rid="CR17">17</xref>]. Even when successfully treated, depressive symptoms are recurrent in about 40% of cases within the first 2&#x000a0;years after treatment [<xref ref-type="bibr" rid="CR18">18</xref>]. If we consider that (1) although antidepressant medication is effective, only 50&#x02013;70% of patients respond to it [<xref ref-type="bibr" rid="CR19">19</xref>], and (2) response rates to cognitive behavioral therapy (CBT), one of the most empirically validated psychological treatments for depression, are also around 60% for moderate to severe depression [<xref ref-type="bibr" rid="CR20">20</xref>], preventing depressive symptoms &#x02014; along with striving for innovative strategies to increase the efficacy of the available treatments &#x02014; becomes critical.</p><sec id="Sec2"><title>Framework and rationale of the study</title><p>Depression prevention efforts represent a global priority [<xref ref-type="bibr" rid="CR21">21</xref>]. A range of interventions, including educational, psychotherapeutic, pharmacological, and lifestyle and nutritional approaches, has been shown to have some utility in preventing the development of this condition [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. However, considering the global challenge raised by depression, there is a need to develop strategies that produce more enduring preventative effects [<xref ref-type="bibr" rid="CR21">21</xref>]. Using insights from the theories at the basis of the best empirically supported psychological treatments available nowadays, such strategies should comprehensively target (1) <italic>cognitive factors</italic> such as negative attitudes or cognitive inflexibility [<xref ref-type="bibr" rid="CR24">24</xref>&#x02013;<xref ref-type="bibr" rid="CR27">27</xref>], and (2) <italic>social stressors</italic> and <italic>behavioral factors</italic> that can activate and/or exacerbate depressive symptoms [<xref ref-type="bibr" rid="CR21">21</xref>]. In addition, innovative methods designed to facilitate the efficient implementation and dissemination of evidence-based prevention strategies are needed. Cuijpers et al. [<xref ref-type="bibr" rid="CR21">21</xref>] suggested that the incorporation of new media, such as e-mental health programs and smartphone solutions, in prevention strategies could prove invaluable in facilitating large-scale implementation of prevention strategies. A similar recommendation has also been advanced by the WHO, which, in its Mental Health Action Plan 2013&#x02013;2020, advises &#x0201d;the promotion of self-care, for instance, through the use of electronic and mobile health technologies&#x0201d; [<xref ref-type="bibr" rid="CR28">28</xref>].</p><p>Recent advances in mobile technology and Internet use have resulted in a niche industry for mental health apps, especially for depression. Searching for &#x0201c;depression&#x0201d; in the Apple Store or Google Apps Store yields hundreds of hits (apps) related to this condition, covering aspects such as measuring depressive symptoms, tracking mood, helping people to think more positively or expressing their gratitude on a regular basis, monitoring dysfunctional thoughts and identifying distorted thinking patterns, challenging dysfunctional thoughts, promoting more diversified activity patterns, and so on. However, how useful they are in terms of preventing or ameliorating depressive symptoms has yet to be established. Preliminary findings showed promising results in reducing subthreshold or mild to moderate depression [<xref ref-type="bibr" rid="CR29">29</xref>&#x02013;<xref ref-type="bibr" rid="CR34">34</xref>]. Still, such studies are small (pilot studies) and few in number, and have not been replicated [<xref ref-type="bibr" rid="CR35">35</xref>].</p><p>The evidence supporting the use of such apps is building up, but additional consistent experimental work is needed before we can draw clear conclusions. To our knowledge, no formalized study has attempted to test the utility of smartphone apps in <italic>preventing</italic> depression. Targeting risk factors for depression, such as cognitive vulnerability [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>] and subthreshold depressive symptomatology [<xref ref-type="bibr" rid="CR15">15</xref>], could represent a first step in building well-informed preventative online programs for this condition (see also [<xref ref-type="bibr" rid="CR38">38</xref>]).</p></sec><sec id="Sec3"><title>Objectives</title><p>The aim of this exploratory study is to test a newly developed app for decreasing cognitive vulnerability in the general adult population, and, respectively, reducing minimal symptoms of depression. To this end, two samples of participants will be recruited: (1) participants free of depressive symptoms, and (2) participants presenting with mild depression symptoms. Within each sample, the participants will be randomized to an active group (i.e., a group receiving preventive intervention) and to a wait-list control, respectively. The clinical utility of the application will be assessed by comparing randomized group scores within each sample type with respect to (1) depressive symptom level, (2) negative and positive effects, (3) satisfaction with life, and (4) behavioral and cognitive vulnerability factors involved in the onset of depression.</p><p>This study will capitalize on one of the main advantages of smartphones, namely broad accessibility. Simply, through this app, we aim to target the majority of smartphone owners, in an attempt to (1) remit minimal depressive symptoms (to prevent their escalation), (2) decrease general cognitive vulnerability for depression and promote protective behaviors, even in the absence of any symptoms, and (3) reduce general negative effect and increase satisfaction with life. This initiative is congruent with recent recommendations in the literature [<xref ref-type="bibr" rid="CR39">39</xref>], as well as with basic CBT principles and empirical evidence, which indicate that supporting individuals in coping with non-clinical psychological distress can prevent symptoms from reaching clinical significance [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. In addition, this app is designed to promote continuous engagement, by incorporating tailoring, customization, and gamification elements, aimed at nurturing intrinsic motivation to use the app. Previous data show that one of the main problems with computerized CBT-based interventions is premature dropout [<xref ref-type="bibr" rid="CR42">42</xref>&#x02013;<xref ref-type="bibr" rid="CR44">44</xref>]. Therefore, though effective and largely accessible [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>], these interventions often do not reach their maximum potential because users prematurely give up using them.</p><p>Borrowing from CBT principles, with a therapeutic package inspired from rational emotive behavior therapy (REBT) [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>], a new application (app) has been developed and will be tested to examine its benefits in decreasing cognitive vulnerability and reducing mild depressive symptomatology as risk factors for depression.</p></sec></sec><sec id="Sec4"><title>Methods/design</title><sec id="Sec5"><title>Trials design</title><p>These are two-arm, parallel-group, randomized controlled exploratory trials examining the effects of an mHealth intervention, developed to decrease cognitive vulnerability and reduce mild depressive symptomatology, compared to wait-list control in people with no symptoms (study 1) and people with mild symptoms (study 2). The participants in the mHealth condition will be followed up for 12&#x000a0;months, and those in the wait-list control group will receive the intervention after they have completed the post-intervention assessment at 4&#x000a0;weeks. The design of the trials is similar to and compliant with the Consolidated Standards of Reporting Trials (CONSORT) guidelines [<xref ref-type="bibr" rid="CR49">49</xref>] and with the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) statement 2013 [<xref ref-type="bibr" rid="CR50">50</xref>] (see also Additional file <xref rid="MOESM1" ref-type="media">1</xref>: SPIRIT checklist and schedule of enrollment, interventions, and assessments).</p></sec><sec id="Sec6"><title>General description of the tested application</title><p>The app to be tested, available for download for iOS and Android, has the following features:<list list-type="order"><list-item><p>Profile and overview section: The first screen of the application (see Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>) after the login summarizes the information about the user&#x02019;s activity in a simple and attractive format. On this screen, the users can choose and personalize an avatar and check the current &#x0201c;Energy&#x0201d; level reached within the application (see details below).<fig id="Fig1"><label>Fig. 1</label><caption><p>App screenshot showing an example of the profile and overview section</p></caption><graphic xlink:href="13063_2016_1740_Fig1_HTML" id="MO1"/></fig>
</p><p>As non-depressed users could be less motivated to use an app designed for clinical use than people suffering from depression, it is important to keep them interested. To this end, the app incorporates an attractive design in both the visual presentation and flow of activities [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. Borrowing from gamification strategies [<xref ref-type="bibr" rid="CR53">53</xref>], the app integrates two graphical representations similar to role-play games: Energy and Level. &#x0201d;Energy&#x0201d; represents a percentage value that decreases over time if the app is not used. The incentive is to keep the Energy level as close to 100% as possible. Reading articles, completing exercises, and filling out questionnaires are all rewarded with an increase in Energy. &#x0201d;Level&#x0201d; represents the user&#x02019;s progress through the educational articles &#x02014; reading each article increases the Level by 1. The goal is to reach the maximum level (i.e., Level 12). This overview also includes a chart representing the user&#x02019;s progress in improving his/her mood over time, measured via a scale in the evaluation section (described below).</p></list-item><list-item><p>Psychoeducation section: This section contains articles and self-help materials covering topics such as the causes of depression, the impact of dysfunctional thinking patterns and unproductive behaviors, healthy and unhealthy negative emotions, as well as a series of educational videos about relaxation techniques.</p></list-item><list-item><p>Exercises: The application contains a series of guided cognitive restructuring exercises, following the ABCDE model of emotional disturbance [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. These exercises are based on a model where each emotion is assigned to several activated events and the specific underlying rational/irrational beliefs &#x02014; so that the user is automatically guided through rational thinking patterns, without the need for therapist feedback (see Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). This is an important aspect of prevention programs, as easy access and &#x0201c;non-consumable&#x0201d; services could be easily provided to a great number of users [<xref ref-type="bibr" rid="CR38">38</xref>]. Completing each activity and exercise is rewarded graphically through a notification and an increase of the Energy percentage.<fig id="Fig2"><label>Fig. 2</label><caption><p>App screenshots showing the &#x0201c;Find irrational beliefs exercise&#x0201d;</p></caption><graphic xlink:href="13063_2016_1740_Fig2_HTML" id="MO2"/></fig>
</p></list-item><list-item><p>Evaluation section: Without leaving the application, the user can fill out questionnaires related to the study being conducted, along with a mood inventory. The mood inventory updates the progress graph on the profile section, described earlier. Whenever a new evaluation is due, the user is notified and rewarded with more Energy after completing it.</p></list-item><list-item><p>Messages section: Each week the users are encouraged, via automated messages, to read articles and use the exercises available. They are also reminded to complete that week&#x02019;s assessment. Moreover, this section allows them to send messages to the research team regarding technical difficulties or other obstacles encountered in using the application&#x02019;s interface.</p></list-item></list>
</p></sec><sec id="Sec7"><title>Study setting</title><p>The study population consists of Romanian adults with (1) no depressive symptomatology (first sample) or (2) with mild depressive symptomatology (second sample). The study is being implemented through the Babe&#x00219;-Bolyai University, Cluj-Napoca, Romania.</p><sec id="Sec8"><title>Eligibility criteria</title><sec id="FPar1"><title>Inclusion criteria for the first trial</title><p>Healthy Romanian-speaking adults (18&#x000a0;years or older) with access to a computer, a smartphone (Android or iOS), and the Internet are included in the study. The Structured Clinical Interview for DSM-IV (SCID) [<xref ref-type="bibr" rid="CR55">55</xref>], specifically the Overview module, will be used to determine the general clinical status of the participants. A clinical psychologist will conduct a short interview aimed to screen for exclusion criteria (see below). Information on drug use and physical and psychological treatment status (past and present) will be collected. In addition, to be included in the study, participants should report a Patient Health Questionnaire (PHQ-9) score no greater than 4.</p></sec><sec id="FPar2"><title>Exclusion criteria for the first trial</title><p>Participants undergoing therapy (i.e., medication and/or psychotherapy), presenting with substance abuse problems, psychotic symptoms, organic brain disorders (e.g., dementia), self-injury or harming others, or serious legal or health issues that would prevent them from using the app, as well as participants reporting scores greater than 1 to Question 9 (suicidal ideation) on the PHQ-9 [<xref ref-type="bibr" rid="CR56">56</xref>] are excluded.</p></sec><sec id="FPar3"><title>Inclusion and exclusion criteria for the second trial</title><p>The inclusion criteria for the second trial will be the same as those for the first trial, except for the PHQ-9 cut-off. More specifically, to be included in the trial, participants should obtain a PHQ-9 score above 4, but no larger than 9. Exclusion criteria for the second trial are identical to those for the first trial.</p></sec></sec></sec><sec id="Sec9"><title>Study conditions: <italic>the mHealth intervention</italic></title><p>The app being tested has two main components: courses and exercises. (1) <italic>Courses</italic> represent the psychoeducational and therapeutic background of the program and include information on the following topics: depression, psychological vulnerability, CBT, healthy and unhealthy negative emotions, rational and irrational thoughts, how behaviors contribute to depression, sleep hygiene, social support, and relaxation techniques. (2) <italic>Exercises</italic> use the information presented in the courses and follow the structure of a regular therapy session and/or therapeutic homework.</p><p>The following exercises are included in the app:<list list-type="order"><list-item><p>The <italic>Emotional Pulse</italic> exercise registers the user&#x02019;s current activity and emotions (healthy or unhealthy).</p></list-item><list-item><p>The <italic>Sticky Notes</italic> exercise consists of a series of tasks targeting behavioral activation (e.g., setting goals, building a list of rewards/pleasant activities).</p></list-item><list-item><p>The <italic>Find Irrational Thoughts</italic> exercise helps to identify thoughts behind the emotions found with the Emotional Pulse exercise.</p></list-item><list-item><p>The <italic>Change Irrational Thoughts</italic> exercise challenges negative/irrational thinking behind unhealthy emotions and replaces it with healthy, flexible, and functional thoughts.</p></list-item></list>
</p><p>The app can be used standalone, i.e., independently by healthy or mildly depressed participants, without therapist guidance.</p></sec><sec id="Sec10"><title>The wait-list control group</title><p>Participants in the delayed intervention group are placed on a wait list for 4&#x000a0;weeks; then they are given full access to the application.</p></sec><sec id="Sec11"><title>Outcomes and measures</title><sec id="Sec12"><title>Primary outcomes</title><p>For the first trial, involving a healthy sample of participants, cognitive vulnerability factors as defined within the CBT paradigm (i.e., dysfunctional cognitions, irrational beliefs, and negative automatic thoughts) [<xref ref-type="bibr" rid="CR24">24</xref>&#x02013;<xref ref-type="bibr" rid="CR26">26</xref>] constitute the primary outcomes. For the second trial, involving a sample of mildly depressed participants, the level of depressive symptomatology constitutes the primary outcome.</p></sec><sec id="Sec13"><title>Secondary outcomes</title><p>For the first trial, the level of depressive symptomatology, the general positive and negative effects, and satisfaction with life constitute the secondary outcomes. Besides depressive symptomatology, emotionality and quality of life outcomes have been included to assess the efficacy of the application on a broader spectrum of psychological variables. For the second trial, the general positive and negative effects and satisfaction with life constitute the secondary outcomes.</p></sec><sec id="Sec14"><title>Other outcomes</title><p>For the first trial, behavioral activation and/or avoidance as possible predictors of the outcomes will be examined. For the second trial, dysfunctional cognitions, irrational beliefs, and negative automatic thoughts (conceptualized as mechanisms of change) and behavioral activation and/or avoidance will be considered as possible predictors of the outcomes.</p><p>Satisfaction with the application and data regarding the app usage are also assessed in both trials.</p><p>The instruments used for each of the above-mentioned outcomes are presented below.</p></sec><sec id="Sec15"><title>Screening measures</title><p>The Overview module of the SCID [<xref ref-type="bibr" rid="CR55">55</xref>] will be used to determine the general clinical status of the participants. Information on drug use and physical and psychological treatment status (past and present) will be collected. The SCID has been adapted for use on the Romanian population [<xref ref-type="bibr" rid="CR57">57</xref>].</p><p>The PHQ-9 [<xref ref-type="bibr" rid="CR56">56</xref>] is a nine-question instrument designed to correspond to the <italic>Diagnostic and Statistical Manual of Mental Disorder,</italic> 4th edition, Revised Text (DSM-IV-TR) [<xref ref-type="bibr" rid="CR58">58</xref>] diagnostic criteria for major depressive disorder. Respondents rate the items from 0 to 3 according to the frequency of their experience over the previous 2-week period (0: not at all; 3: nearly every day). The score can then be interpreted as indicating the depression severity (no depression, mild, moderate, moderately severe, or severe depression). The PHQ-9 has been adapted into Romanian for the purposes of the current study.</p></sec><sec id="Sec16"><title>Measures of primary, secondary, and other outcomes</title><p>The level of depressive symptomatology is assessed with the Center for Epidemiologic Studies Depression Scale-Revised (CESD-R) [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. The CESD-R is a 20-item self-report instrument which measures symptoms of depression in nine different categories: sadness (dysphoria), loss of interest (anhedonia), appetite, sleep, thinking/concentration, guilt (worthlessness), tiredness (fatigue), movement (agitation), and suicidal ideation. Participants rate each item on a five-point Likert scale, from 0 (not at all or less than one day) to 4 (nearly every day for 2&#x000a0;weeks) to indicate how they felt or behaved during the last week or so. The Total CESD-R Score is calculated as a sum of responses to all 20 questions. The CESD-R exhibited good psychometric properties, including high internal consistency, strong factor loadings, and theoretically consistent convergent and divergent validity with anxiety, schizotypy, and positive and negative effects [<xref ref-type="bibr" rid="CR61">61</xref>]. The CESD-R has been adapted to Romanian for the purposes of the current study.</p><p>
<italic>The Positive and Negative Affect Scale</italic> (PANAS) [<xref ref-type="bibr" rid="CR62">62</xref>] is a 20-item self-report questionnaire designed to assess mood. It consists of 10 items that address positive affect (PA) and 10 items that address negative affect (NA). Participants rate each item on a five-point Likert scale, from 1 (very slightly/not at all) to 5 (extremely) to indicate how they felt during the indicated timeframe. The PANAS can be used to assess mood on various time scales by altering the instructions. For the purposes of this study, we have used a 2-week timeframe. The validity and internal consistency of the PANAS are good, with test&#x02013;retest reliability being the highest for the &#x0201c;general&#x0201d; temporal instruction. The PANAS has been used previously on the Romanian population and was found to have adequate psychometric properties [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR64">64</xref>].</p><p>
<italic>Satisfaction with Life</italic> (SWL) [<xref ref-type="bibr" rid="CR65">65</xref>] is a five-item scale designed to measure global cognitive judgements of one&#x02019;s life satisfaction. Participants rate each of the five items using a seven-point scale that ranges from 7 (strongly agree) to 1 (strongly disagree). The SWL has been shown to be a valid and reliable measure of life satisfaction which can be used with a wide range of age groups [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR67">67</xref>]. The SWL scale has been adapted to Romanian for the purposes of the current study.</p><p>
<italic>The Dysfunctional Attitude Scale</italic> (DAS) [<xref ref-type="bibr" rid="CR68">68</xref>] was designed to measure the intensity of dysfunctional attitudes that, according to the cognitive theory of depression [<xref ref-type="bibr" rid="CR25">25</xref>], contribute to vulnerability for depression. For the purpose of our study, we used the short form of this scale. The Dysfunctional Attitude Scale - Short Form (DAS-SF) [<xref ref-type="bibr" rid="CR69">69</xref>] consists of two subscales: &#x0201c;dependency&#x0201d; (6 items) and &#x0201c;perfectionism/performance evaluation&#x0201d; (11 items). The 17 items are rated on a seven-point Likert scale, from 1 (total disagreement) to 7 (total agreement). The DAS-SF possesses good psychometric properties in terms of model fit, reliability, and convergent construct validity [<xref ref-type="bibr" rid="CR69">69</xref>]. The DAS-SF has been adapted to Romanian for the purposes of this study.</p><p>
<italic>The Beliefs Scale</italic> (BS) [<xref ref-type="bibr" rid="CR70">70</xref>] measures irrational beliefs. It consists of 20 items, and responders indicate how much they agree or disagree with each item using a five-point Likert scale that ranges from 1 (strongly disagree) to 5 (strongly agree). The BS shows good psychometric properties regarding construct and discriminant validity [<xref ref-type="bibr" rid="CR71">71</xref>]. This scale has been translated into Romanian for the purposes of this study.</p><p>
<italic>The Automatic Thoughts Questionnaire</italic> (ATQ) [<xref ref-type="bibr" rid="CR72">72</xref>] is a 15-item self-report measure used to assess depression-related cognitions. Participants rate, on a five-point Likert scale from 1 (never) to 5 (almost all the time), how frequently they have had a given thought over the past week. A higher score shows a higher frequency of automatic thoughts. The psychometric properties of the ATQ have been adequately demonstrated in previous studies [<xref ref-type="bibr" rid="CR73">73</xref>]. The ATQ has been successfully used previously on the Romanian population [<xref ref-type="bibr" rid="CR74">74</xref>&#x02013;<xref ref-type="bibr" rid="CR76">76</xref>].</p><p>
<italic>The Behavioral Activation for Depression Scale - Short Form</italic> (BADS-SF) [<xref ref-type="bibr" rid="CR77">77</xref>] is an instrument designed to be administered weekly to measure changes in avoidance and activation over the course of the Behavioral Activation (BA) treatment for depression. The BADS consists of nine items grouped into two subscales (Activation and Avoidance/Rumination). Respondents rate each item on a seven-point Likert scale ranging from 0 (not at all) to 6 (completely). The scale has good psychometric properties [<xref ref-type="bibr" rid="CR78">78</xref>]. The BADS-SF has been translated into Romanian for the purposes of this study.</p><p>
<italic>Satisfaction with the Application Scale</italic> was specifically designed for this study. It consists of 10 items that assess users&#x02019; satisfaction with the application, its difficulty level, attractiveness, and subjective utility. The first 8 items are rated on a three-point scale, ranging from 0 to 2. Each response scale is personalized to the content of the item (e.g., How attractive did you find the exercises included in the application? - 0&#x02009;=&#x02009;rather unattractive, 1&#x02009;=&#x02009;attractive enough, 2&#x02009;=&#x02009;very attractive). Item 9 assesses the application globally, with the participant being asked to give an overall grade between 1 (minimum) and 10 (maximum). Item 10 asks the participants if they would recommend the application to a friend ("yes" or "no").</p><p>
<italic>The Application Use Scale</italic> was also developed specifically for this study. It consists of 8 items that assess weekly quantitative app usage aspects: the effort invested in homework (1 item), number of practiced exercises (1 item), number of read courses (1 item), frequency of general application use (1 item), and frequency of every exercise use (4 items).</p><p>Two Romanian English-proficient post-doctoral clinical psychologists, with good knowledge of the constructs measured, independently translated all the instruments adapted into Romanian for the purposes of the present study. Disagreements were resolved through discussions between the translators. A senior clinical psychologist and the principal investigator also reviewed and approved the final versions.</p></sec><sec id="Sec17"><title>Participant timeline</title><p>Possible participants are invited to access the study's website [<xref ref-type="bibr" rid="CR79">79</xref>] and, after carefully reading the information package, they are instructed to create an online account. The participants are then asked to answer a few demographic questions (i.e., report on their age, education, status on the labor market, and marital/co-habitation status) and complete the PHQ-9 to determine their eligibility for further evaluation. If eligible, a screening procedure is implemented. A short telephone interview screens out those people whose interest in the study is motivated by issues other than their mood (e.g., curiosity, practical/life problems, need for a psychological assessment). Applicants who do not meet the inclusion criteria are informed via email. They are thanked for their interest, given a summary score and interpretation for their PHQ-9 score, and encouraged to discuss their problems with a professional, if necessary. Information on how to reach a clinical psychologist or psychotherapist is also provided.</p><p>Participants meeting inclusion criteria will be randomly assigned to one of the two conditions: immediate online intervention condition (mHealth intervention) or the delayed-intervention condition (see the flow diagram in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). Subsequent assessments consist of all the above instruments. Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref> shows the schedule of enrollment, interventions, and assessments.<fig id="Fig3"><label>Fig. 3</label><caption><p>CONSORT flow diagram [<xref ref-type="bibr" rid="CR49">49</xref>] showing subject allocation to the study conditions</p></caption><graphic xlink:href="13063_2016_1740_Fig3_HTML" id="MO3"/></fig>
<fig id="Fig4"><label>Fig. 4</label><caption><p>Schedule of enrollment, interventions, and assessments. *t<sub>1x</sub> and t<sub>2x</sub> represent weekly separate assessments</p></caption><graphic xlink:href="13063_2016_1740_Fig4_HTML" id="MO4"/></fig>
</p><p>The participants in the mHealth intervention are assessed at pre-intervention (time 1, baseline), at mid-intervention (time 2, 2&#x000a0;weeks after baseline), at post-intervention (time 3, 4&#x000a0;weeks after baseline), and at 3, 6, and 12&#x000a0;months post-intervention (times 4, 5, and 6). The participants in the delayed-intervention condition are assessed before the waiting period (time 1, baseline), at mid-waiting period (time 2, 2&#x000a0;weeks after baseline), and at post-waiting period (time 3, 4&#x000a0;weeks after baseline).</p><p>Participants assigned to the mHealth intervention will be given access to the online application along with explicit instructions regarding the use of all of its sections. Participants will be given 4&#x000a0;weeks to complete the intervention, during which time weekly messages will be sent out to them. Messages include regular assignments designed for a complete and thorough use of the application's courses and exercises, and encourage the review of materials whenever possible. However, participants are free to use the application at their own pace.</p><p>After each week, participants&#x02019; application use is evaluated (see the <italic>Application Use Scale</italic> described above). Similarly, after each week of using the application, the participants are required to complete the CESD-R for close monitoring of their depressive symptomatology and individualized feedback on their emotional state.</p><p>Participants in the delayed intervention group are placed on a wait list for 4&#x000a0;weeks.</p></sec></sec><sec id="Sec18"><title>Sample size</title><p>The sample size was estimated considering the exploratory nature of the two trials, in terms of investigating the feasibility of the design and methodology employed, as well as app-related usability aspects. As such, we followed current research practice exploratory protocols. For example, in an audit of sample sizes for pilot and feasibility trials being undertaken in the UK, Billingham, Whitehead, and Julious [<xref ref-type="bibr" rid="CR80">80</xref>] have found that the median pilot study sample size for two-arm trials was 30 participants per arm, for continuous endpoints. Taking this into consideration, as well as promising results (i.e., large within-group effect sizes) reported by previous studies testing mobile phone applications for depression [<xref ref-type="bibr" rid="CR81">81</xref>], a total number of 50 participants per study (i.e., 50 participants without depressive symptomatology and 50 participants with mild depressive symptomatology) was anticipated.</p></sec><sec id="Sec19"><title>Recruitment</title><p>Possible participants are approached through presentations at various events and ads in the media. Additionally, clinicians from the private practice area are contacted for referrals. Those interested in using the application are asked to provide their contact details and are subsequently contacted via email, at which point the enrollment procedure is described.</p></sec><sec id="Sec20"><title>Assignment to study group</title><p>The participants are assigned to one of the two trials, depending on their depressive symptomatology level (i.e., PHQ-9 score). Using the software Randomizer.org, participants are then randomly distributed to one of the trials&#x02019; conditions. Randomization is performed by a research assistant using a simple (unrestricted) randomization sequence that assigns two unique numbers per participant; the number assigned is either 1 or 2, according to the number of experimental conditions. To conceal the allocation mechanism, the same research assistant will monitor the assessments and allow access to the application for the participants in the wait-list control group, after 1&#x000a0;month. The principal investigator and the statisticians running the data analysis will remain blinded to the study condition until the completion of the study.</p></sec><sec id="Sec21"><title>Data collection, management, and analyses</title><sec id="Sec22"><title>Data collection methods</title><p>The data are collected within the application, in the Evaluation section, and transferred to our servers using an encrypted, secure (https) industry-standard transfer protocol.</p><p>The following strategies will be implemented to promote participant retention and follow-up completion. First of all, participants are reminded every week of the specific assessment that needs to be completed, through the Messages section, and are rewarded with more &#x0201d;Energy&#x0201d; after completing it. Participants are also told that the weekly completion of the mood questionnaires allows the app to create a personalized profile of their mood (through the profile section) and, thus, give individualized feedback on their emotional state. Furthermore, the messages that the participants receive every week comprise gradual steps in covering the app&#x02019;s content and exercises &#x02014; every message refers to a new content and/or new exercise to be covered during that week, explaining its purpose and possible use, and, at the same time, encouraging the participant to come back the next week. Lastly, for the follow-up assessments, participants will receive new messages reminding them that the free use of the app was possible because of a research grant, for which the collection of this data is essential.</p></sec><sec id="Sec23"><title>Statistical methods</title><p>Improvement in the primary outcomes measures scores within and between the groups (for each study) will be examined using mixed-effects linear regression analysis with a random intercept and slope over time (three assessments: baseline, mid-intervention, post-intervention) and fixed effects for intervention assignment. The 3-, 6-, and 12-month follow-up data will be analyzed in a separate fixed-effects model. The main analysis will compare groups (experimental and wait-list) in terms of cognitive vulnerability factors for the first trial, or level of depressive symptoms for the second trial. When analysis of secondary/other outcomes is performed, the error probability will be adjusted according to the number of group comparisons performed.</p><p>An intent-to-treat analysis will also be performed to examine participants who dropped out prematurely.</p><p>App usage data and user activity will be examined in an exploratory manner by comparing the participants&#x02019; self-reported activity with their actual app usage as captured by our software. This wealth of data will allow the possibility of pinpointing any obstacles to user adherence to the protocol, and will shed light on the reasons for dropouts or irregular usage patterns.</p></sec></sec><sec id="Sec24"><title>Monitoring study implementation</title><p>Two clinical psychologists, members of the study team, screen for the risk of unintended effects or harm to the participants (i.e., clinically significant increase in depressive symptomatology, as measured by the CESD-R). The psychologists monitor the weekly online evaluations and clinically interpret the CESD-R score of every participant. If the participant does not complete the CESD-R evaluation, she/he is contacted by telephone. If necessary, the supervisor can decide to interrupt the participant's access to the application and make a further referral.</p></sec><sec id="Sec25"><title>Ethics and dissemination</title><p>The ethics commission at Babe&#x00219;-Bolyai University has approved this study. Although it does not involve the delivery of a treatment to depressed people, it does target individuals with mild depressive symptomatology who may be at risk for developing depression. Hence, there are ethical concerns that need to be addressed. Firstly, the initial screening process and the exclusionary criteria single out people at risk for suicide, who are immediately referred to the appropriate clinical care. Secondly, if a participant&#x02019;s condition worsens during the use of the application, the clinical team can opt to interrupt his/her access to the application and make a further referral or recommendation. Regarding confidentiality, special attention has been given to securing the online data collection and storage. Sensitive clinical data are collected either through a web browser (during the signup procedure) or from the mobile application. Both these means communicate the data to the server over industry-standard secure connections (i.e., https). The server stores the data in a database that is not publicly accessible. The system running our applications is kept up to date to prevent intrusions. Access to the electronic data is password-protected, and the passwords are changed regularly. The clinical screening reports contain no personal identifying information.</p></sec><sec id="Sec26"><title>Dissemination policy</title><p>Preliminary features of the application and its intended purpose have been presented at several conferences, nationally and internationally. Also, this research is being promoted and constantly updated in terms of progress and dissemination through its designated website [<xref ref-type="bibr" rid="CR82">82</xref>]. The two trials&#x02019; results will be submitted for publication in peer-reviewed journals, focusing on (1) feasibility and usability results and (2) primary and secondary outcome results. New presentations at international conferences on the topic of e-health solutions are also being considered.</p></sec></sec><sec id="Sec27"><title>Discussion</title><p>This exploratory study describes two randomized clinical trials testing a smartphone app aimed at reducing cognitive vulnerability and mild depressive symptoms, as risk factors for the onset of depression. The two trials&#x02019; targets are (1) the general population and (2) a population with minimal depressive symptoms. This research effort is motivated by the global challenge that depression raises. Depression prevalence and costs have continuously increased over the years [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR83">83</xref>]. Subthreshold depression also has a high prevalence [<xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR85">85</xref>], is associated with considerable individual and societal costs [<xref ref-type="bibr" rid="CR86">86</xref>, <xref ref-type="bibr" rid="CR87">87</xref>], and predicts future full-blown depressive episodes [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR88">88</xref>]. Depressive symptoms usually do not remit without treatment [<xref ref-type="bibr" rid="CR89">89</xref>], yet access to interventions is limited [<xref ref-type="bibr" rid="CR1">1</xref>], responses to available treatments are suboptimal [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>], and recurrence rates are substantial&#x000a0;[<xref ref-type="bibr" rid="CR18">18</xref>]. Therefore, large-scale preventative strategies <italic>before</italic> people experience depressive disorders (when they are in need for full treatment) are needed.</p><p>To our knowledge, this is the first attempt to capitalize on the ubiquity of smartphones to large-scale dissemination of CBT-based strategies aimed at preventing depression in non-clinical populations. By generating the first indirect evidence related to the potential value of apps for preventing depression, through decrease in cognitive vulnerability and reduction of depressive symptoms, this study can add substantially to the relatively small body of evidence indicating that smartphone apps could be successfully used to manage depression [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR90">90</xref>]. The app developed for this study is designed to decrease general cognitive vulnerability and promote engagement in protective, adaptive activities, while counteracting the tendency of premature dropout (through gamification and customization). This study capitalizes on targeting cognitive vulnerability factors as mechanisms of change. Notably, studies conducted until now have focused almost exclusively on testing the apps clinical efficacy in decreasing symptoms. The investigation of the mechanisms of change in relation to technologically mediated CBT preventive/intervention strategies seems to be grossly under-investigated. By including two types of samples recruited from a general, non-clinical population (i.e., symptom-free participants, and participants showing minimal symptoms of depression, respectively), this research may be able to add support to the assumption that symptoms remission/lowering is explained by a decrease in cognitive vulnerability [<xref ref-type="bibr" rid="CR25">25</xref>]. Although the study design does not allow the provision of irrefutable support for such an assumption, the results do have the potential of guiding future research.</p><p>There are, however, limitations of this study. The main one is related to the control group. Ideally, an active placebo control should be included. Yet, because there are no studies investigating the potential utility of apps in preventing depressive symptoms in a non-clinical population, a simple wait-list control was included. Nevertheless, this implies that, if the expected results are obtained, the possibility that they are explained by the simple usage of the app, rather than the app content, will not be ruled out. However, because a decrease in symptoms is not the main or the sole indicator of the app&#x02019;s efficacy but, rather, may be a possible change in cognitive vulnerability factors in a population free of marked psychological distress, the authors believe that the simple usage of the app is unlikely to explain eventual positive results. However, future studies should strive to contrast the &#x0201c;active&#x0201d; app with a &#x0201c;sham&#x0201d; app (i.e., an alternative app which looks similar, but does not target cognitive vulnerability factors associated with depression) in order to derive firm conclusions.</p></sec><sec id="Sec28"><title>Trial status</title><p>Participant recruitment began on 7 June 2016. Randomization of the participants was performed on 15 June 2016.</p></sec></body><back><app-group><app id="App1"><sec id="Sec29"><title>Additional file</title><p>
<media position="anchor" xlink:href="13063_2016_1740_MOESM1_ESM.doc" id="MOESM1"><label>Additional file 1:</label><caption><p>SPIRIT 2013 checklist: recommended items to address in a clinical trial protocol and related documents. (DOC 122 kb)</p></caption></media>
</p></sec></app></app-group><glossary><title>Abbreviations</title><def-list><def-item><term>ATQ</term><def><p>Automatic Thoughts Questionnaire</p></def></def-item><def-item><term>BADS-SF</term><def><p>Behavioral Activation for Depression Scale - Short Form</p></def></def-item><def-item><term>BS</term><def><p>Beliefs Scale</p></def></def-item><def-item><term>CBT</term><def><p>Cognitive behavioral therapy</p></def></def-item><def-item><term>CESD-R</term><def><p>Center for Epidemiologic Studies Depression Scale-Revised</p></def></def-item><def-item><term>DAS</term><def><p>Dysfunctional Attitude Scale</p></def></def-item><def-item><term>DAS-SF</term><def><p>Dysfunctional Attitudes Scale - Short Form</p></def></def-item><def-item><term>DSM-IV-TR</term><def><p>Diagnostic and Statistical Manual of Mental Disorders 4th edition</p></def></def-item><def-item><term>GDB</term><def><p>Global disease burden</p></def></def-item><def-item><term>PANAS</term><def><p>Positive and Negative Affect Scale</p></def></def-item><def-item><term>PHQ-9</term><def><p>Patient Health Questionnaire, 9-item version</p></def></def-item><def-item><term>REBT</term><def><p>Rational emotive behavior therapy</p></def></def-item><def-item><term>SWL</term><def><p>Satisfaction with Life</p></def></def-item><def-item><term>WHO</term><def><p>World Health Organization</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>The authors thank CheckWare (Trondheim, Norway) for their support in the implementation of data collection and Prof. Tore Stiles (Norwegian University of Science and Technology &#x02013; NTNU, Trondheim, Norway) for his feedback on the app features.</p><sec id="FPar4"><title>Funding</title><p>The research leading to these results has received funding from EEA Financial Mechanism 2009&#x02013;2014 under project contract number 12 SEE/30.06.2014, grant number EEA-JRP-RO-NO-2013-1-0358. The funding body has no role in the study design and implementation, writing the report, or decision to submit the report for publication.</p></sec><sec id="FPar5"><title>Availability of data and materials</title><p>Upon the completion of the study, supporting data will be available upon request.</p></sec><sec id="FPar6"><title>Authors&#x02019; contributions</title><p>CG, CM, and OC contributed to the study design and drafted and revised the manuscript. CG and VM contributed to the app design and features. AS contributed to the design of the randomized controlled trials. RB developed the software. CG approved the final draft of the manuscript. All authors read and approved the final manuscript.</p></sec><sec id="FPar7"><title>Authors&#x02019; information</title><p>Not applicable.</p></sec><sec id="FPar8"><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec id="FPar9"><title>Consent for publication</title><p>Not applicable.</p></sec><sec id="FPar10"><title>Ethics approval and consent to participate</title><p>The Ethics Committee at the Babes-Bolyai University in Cluj-Napoca, Romania, has approved this study. All participants signed the informed consent form.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">World Health Organization. Depression. 2016. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/mediacentre/factsheets/fs369/en/">http://www.who.int/mediacentre/factsheets/fs369/en/</ext-link>.&#x000a0;Accessed 8 Apr 2016.</mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">World Health Organization. Policies and practices for mental health in Europe. Meeting the challenges. 2016. <ext-link ext-link-type="uri" xlink:href="http://www.euro.who.int/en/publications/abstracts/policies-and-practices-for-mental-health-in-europe.-meeting-the-challenges">http://www.euro.who.int/en/publications/abstracts/policies-and-practices-for-mental-health-in-europe.-meeting-the-challenges</ext-link>.&#x000a0;Accessed 8 Apr 2016.</mixed-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrari</surname><given-names>AJ</given-names></name><name><surname>Charlson</surname><given-names>FJ</given-names></name><name><surname>Norman</surname><given-names>RE</given-names></name><name><surname>Patten</surname><given-names>SB</given-names></name><name><surname>Freedman</surname><given-names>G</given-names></name><name><surname>Murray</surname><given-names>CJL</given-names></name><name><surname>Vos</surname><given-names>T</given-names></name><name><surname>Whiteford</surname><given-names>HA</given-names></name></person-group><article-title>Burden of depressive disorders by country, sex, age, and year: findings from the Global Burden of Disease study 2010</article-title><source>PLoS Med</source><year>2013</year><volume>10</volume><fpage>e1001547</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1001547</pub-id><pub-id pub-id-type="pmid">24223526</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">World Health Organization. Global burden of mental disorders and the need for a comprehensive, coordinated response from health and social sectors at the country level. 2011. <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/gb/ebwha/pdf_files/EB130/B130_9-en.pdf">http://apps.who.int/gb/ebwha/pdf_files/EB130/B130_9-en.pdf</ext-link>.&#x000a0;Accessed 14 Apr 2016.</mixed-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenberg</surname><given-names>PE</given-names></name><name><surname>Kessler</surname><given-names>RC</given-names></name><name><surname>Birnbaum</surname><given-names>HG</given-names></name><name><surname>Leong</surname><given-names>SA</given-names></name><name><surname>Lowe</surname><given-names>SW</given-names></name><name><surname>Berglund</surname><given-names>PA</given-names></name><name><surname>Corey-Lisle</surname><given-names>PK</given-names></name></person-group><article-title>The economic burden of depression in the United States: how did it change between 1990 and 2000?</article-title><source>J Clin Psychiatry</source><year>2003</year><volume>64</volume><fpage>1465</fpage><lpage>1475</lpage><pub-id pub-id-type="doi">10.4088/JCP.v64n1211</pub-id><pub-id pub-id-type="pmid">14728109</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olesen</surname><given-names>J</given-names></name><name><surname>Gustavsson</surname><given-names>A</given-names></name><name><surname>Svensson</surname><given-names>M</given-names></name><name><surname>Wittchen</surname><given-names>H-U</given-names></name><name><surname>J&#x000f6;nsson</surname><given-names>B</given-names></name></person-group><article-title>The economic cost of brain disorders in Europe</article-title><source>Eur J Neurol</source><year>2012</year><volume>19</volume><fpage>155</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1111/j.1468-1331.2011.03590.x</pub-id><pub-id pub-id-type="pmid">22175760</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobocki</surname><given-names>P</given-names></name><name><surname>J&#x000f6;nsson</surname><given-names>B</given-names></name><name><surname>Angst</surname><given-names>J</given-names></name><name><surname>Rehnberg</surname><given-names>C</given-names></name></person-group><article-title>Cost of depression in Europe</article-title><source>J Ment Health Policy Econ</source><year>2006</year><volume>9</volume><fpage>87</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">17007486</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuijpers</surname><given-names>P</given-names></name><name><surname>Sijbrandij</surname><given-names>M</given-names></name><name><surname>Koole</surname><given-names>SL</given-names></name><name><surname>Andersson</surname><given-names>G</given-names></name><name><surname>Beekman</surname><given-names>AT</given-names></name><name><surname>Reynolds</surname><given-names>CF</given-names></name></person-group><article-title>The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons</article-title><source>World Psychiatry</source><year>2013</year><volume>12</volume><fpage>137</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1002/wps.20038</pub-id><pub-id pub-id-type="pmid">23737423</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofmann</surname><given-names>SG</given-names></name><name><surname>Asnaani</surname><given-names>A</given-names></name><name><surname>Vonk</surname><given-names>IJJ</given-names></name><name><surname>Sawyer</surname><given-names>AT</given-names></name><name><surname>Fang</surname><given-names>A</given-names></name></person-group><article-title>The efficacy of cognitive behavioral therapy: a review of meta-analyses</article-title><source>Cogn Ther Res</source><year>2012</year><volume>36</volume><fpage>427</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1007/s10608-012-9476-1</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenberg</surname><given-names>PE</given-names></name><name><surname>Fournier</surname><given-names>A-A</given-names></name><name><surname>Sisitsky</surname><given-names>T</given-names></name><name><surname>Pike</surname><given-names>CT</given-names></name><name><surname>Kessler</surname><given-names>RC</given-names></name></person-group><article-title>The economic burden of adults with major depressive disorder in the United States (2005 and 2010)</article-title><source>J Clin Psychiatry</source><year>2015</year><volume>76</volume><fpage>155</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.4088/JCP.14m09298</pub-id><pub-id pub-id-type="pmid">25742202</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hidaka</surname><given-names>BH</given-names></name></person-group><article-title>Depression as a disease of modernity: explanations for increasing prevalence</article-title><source>J Affect Disord</source><year>2012</year><volume>140</volume><fpage>205</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2011.12.036</pub-id><pub-id pub-id-type="pmid">22244375</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000e9;pine</surname><given-names>J-P</given-names></name><name><surname>Briley</surname><given-names>M</given-names></name></person-group><article-title>The increasing burden of depression</article-title><source>Neuropsychiatr Dis Treat</source><year>2011</year><volume>7</volume><issue>Suppl 1</issue><fpage>3</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">21750622</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuijpers</surname><given-names>P</given-names></name></person-group><article-title>The patient perspective in research on major depression</article-title><source>BMC Psychiatry</source><year>2011</year><volume>11</volume><fpage>89</fpage><pub-id pub-id-type="doi">10.1186/1471-244X-11-89</pub-id><pub-id pub-id-type="pmid">21592336</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldman</surname><given-names>LS</given-names></name><name><surname>Nielsen</surname><given-names>NH</given-names></name><name><surname>Champion</surname><given-names>HC</given-names></name></person-group><article-title>Awareness, diagnosis, and treatment of depression</article-title><source>J Gen Intern Med</source><year>1999</year><volume>14</volume><fpage>569</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1046/j.1525-1497.1999.03478.x</pub-id><pub-id pub-id-type="pmid">10491249</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuijpers</surname><given-names>P</given-names></name><name><surname>Smit</surname><given-names>F</given-names></name></person-group><article-title>Subthreshold depression as a risk indicator for major depressive disorder: a systematic review of prospective studies</article-title><source>Acta Psychiatr Scand</source><year>2004</year><volume>109</volume><fpage>325</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0447.2004.00301.x</pub-id><pub-id pub-id-type="pmid">15049768</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fava</surname><given-names>GA</given-names></name><name><surname>Park</surname><given-names>SK</given-names></name><name><surname>Sonino</surname><given-names>N</given-names></name></person-group><article-title>Treatment of recurrent depression</article-title><source>Expert Rev Neurother</source><year>2006</year><volume>6</volume><fpage>1735</fpage><lpage>1740</lpage><pub-id pub-id-type="doi">10.1586/14737175.6.11.1735</pub-id><pub-id pub-id-type="pmid">17144786</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Limosin</surname><given-names>F</given-names></name><name><surname>Mekaoui</surname><given-names>L</given-names></name><name><surname>Hautecouverture</surname><given-names>S</given-names></name></person-group><article-title>Strat&#x000e9;gies th&#x000e9;rapeutiques prophylactiques dans la d&#x000e9;pression unipolaire</article-title><source>Presse Med</source><year>2007</year><volume>36</volume><issue>11, Part 2</issue><fpage>1627</fpage><lpage>1633</lpage><pub-id pub-id-type="doi">10.1016/j.lpm.2007.03.032</pub-id><pub-id pub-id-type="pmid">17555914</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Boland</surname><given-names>R</given-names></name><name><surname>Keller</surname><given-names>M</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Gotlib</surname><given-names>IH</given-names></name><name><surname>Hammen</surname><given-names>HL</given-names></name></person-group><article-title>Course and outcome of depression</article-title><source>Handbook of Depression</source><year>2009</year><edition>2</edition><publisher-loc>New York</publisher-loc><publisher-name>Guilford Press</publisher-name></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gartlehner</surname><given-names>G</given-names></name><name><surname>Hansen</surname><given-names>RA</given-names></name><name><surname>Thieda</surname><given-names>P</given-names></name><name><surname>DeVeaugh-Geiss</surname><given-names>AM</given-names></name><name><surname>Gaynes</surname><given-names>BN</given-names></name><name><surname>Krebs</surname><given-names>EE</given-names></name><name><surname>Lux</surname><given-names>LJ</given-names></name><name><surname>Morgan</surname><given-names>LC</given-names></name><name><surname>Shumate</surname><given-names>JA</given-names></name><name><surname>Monroe</surname><given-names>LG</given-names></name><name><surname>Lohr</surname><given-names>KN</given-names></name></person-group><source>Comparative effectiveness of second-generation antidepressants in the pharmacologic treatment of adult depression</source><year>2007</year><publisher-loc>Rockville</publisher-loc><publisher-name>Agency for Healthcare Research and Quality (US)</publisher-name></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeRubeis</surname><given-names>RJ</given-names></name><name><surname>Hollon</surname><given-names>SD</given-names></name><name><surname>Amsterdam</surname><given-names>JD</given-names></name><name><surname>Shelton</surname><given-names>RC</given-names></name><name><surname>Young</surname><given-names>PR</given-names></name><name><surname>Salomon</surname><given-names>RM</given-names></name><name><surname>O&#x02019;Reardon</surname><given-names>JP</given-names></name><name><surname>Lovett</surname><given-names>ML</given-names></name><name><surname>Gladis</surname><given-names>MM</given-names></name><name><surname>Brown</surname><given-names>LL</given-names></name><name><surname>Gallop</surname><given-names>R</given-names></name></person-group><article-title>Cognitive therapy vs medications in the treatment of moderate to severe depression</article-title><source>Arch Gen Psychiatry</source><year>2005</year><volume>62</volume><fpage>409</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1001/archpsyc.62.4.409</pub-id><pub-id pub-id-type="pmid">15809408</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuijpers</surname><given-names>P</given-names></name><name><surname>Beekman</surname><given-names>ATF</given-names></name><name><surname>Reynolds</surname><given-names>CF</given-names></name></person-group><article-title>Preventing depression</article-title><source>JAMA</source><year>2012</year><volume>307</volume><fpage>1033</fpage><lpage>1034</lpage><pub-id pub-id-type="doi">10.1001/jama.2012.271</pub-id><pub-id pub-id-type="pmid">22416097</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mu&#x000f1;oz</surname><given-names>RF</given-names></name><name><surname>Beardslee</surname><given-names>WR</given-names></name><name><surname>Leykin</surname><given-names>Y</given-names></name></person-group><article-title>Major depression can be prevented</article-title><source>Am Psychol</source><year>2012</year><volume>67</volume><fpage>285</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1037/a0027666</pub-id><pub-id pub-id-type="pmid">22583342</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buntrock</surname><given-names>C</given-names></name><name><surname>Ebert</surname><given-names>DD</given-names></name><name><surname>Lehr</surname><given-names>D</given-names></name><name><surname>Smit</surname><given-names>F</given-names></name><name><surname>Riper</surname><given-names>H</given-names></name><name><surname>Berking</surname><given-names>M</given-names></name><name><surname>Cuijpers</surname><given-names>P</given-names></name></person-group><article-title>Effect of a web-based guided self-help intervention for prevention of major depression in adults with subthreshold depression: a randomized clinical trial</article-title><source>JAMA</source><year>2016</year><volume>315</volume><fpage>1854</fpage><lpage>1863</lpage><pub-id pub-id-type="doi">10.1001/jama.2016.4326</pub-id><pub-id pub-id-type="pmid">27139058</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>AT</given-names></name></person-group><article-title>Thinking and depression: I. idiosyncratic content and cognitive distortions</article-title><source>Arch Gen Psychiatry</source><year>1963</year><volume>9</volume><fpage>324</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1001/archpsyc.1963.01720160014002</pub-id><pub-id pub-id-type="pmid">14045261</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>AT</given-names></name></person-group><source>Cognitive therapy and the emotional disorders</source><year>1976</year><publisher-loc>New York</publisher-loc><publisher-name>International Universities Press</publisher-name></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellis</surname><given-names>A</given-names></name></person-group><article-title>Rational psychotherapy and individual psychology</article-title><source>J Individ Psychol</source><year>1957</year><volume>13</volume><fpage>38</fpage><lpage>44</lpage></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haeffel</surname><given-names>GJ</given-names></name><name><surname>Rozek</surname><given-names>DC</given-names></name><name><surname>Hames</surname><given-names>JL</given-names></name><name><surname>Technow</surname><given-names>J</given-names></name></person-group><article-title>Too much of a good thing: testing the efficacy of a cognitive bias modification task for cognitively vulnerable individuals</article-title><source>Cogn Ther Res</source><year>2011</year><volume>36</volume><fpage>493</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1007/s10608-011-9379-6</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="other">World Health Organization. Mental Health Action Plan: 2013&#x02013;2020. <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/10665/89966/1/9789241506021_eng.pdf">http://apps.who.int/iris/bitstream/10665/89966/1/9789241506021_eng.pdf</ext-link>.&#x000a0;Accessed 11 Apr 2016.</mixed-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birney</surname><given-names>AJ</given-names></name><name><surname>Gunn</surname><given-names>R</given-names></name><name><surname>Russell</surname><given-names>JK</given-names></name><name><surname>Ary</surname><given-names>DV</given-names></name></person-group><article-title>MoodHacker mobile Web app with email for adults to self-manage mild-to-moderate depression: randomized controlled trial</article-title><source>JMIR Mhealth Uhealth</source><year>2016</year><volume>4</volume><issue>1</issue><fpage>e8</fpage><pub-id pub-id-type="doi">10.2196/mhealth.4231</pub-id><pub-id pub-id-type="pmid">26813737</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burns</surname><given-names>MN</given-names></name><name><surname>Begale</surname><given-names>M</given-names></name><name><surname>Duffecy</surname><given-names>J</given-names></name><name><surname>Gergle</surname><given-names>D</given-names></name><name><surname>Karr</surname><given-names>CJ</given-names></name><name><surname>Giangrande</surname><given-names>E</given-names></name><name><surname>Mohr</surname><given-names>DC</given-names></name></person-group><article-title>Harnessing context sensing to develop a mobile intervention for depression</article-title><source>J Med Internet Res</source><year>2011</year><volume>13</volume><fpage>e55</fpage><pub-id pub-id-type="doi">10.2196/jmir.1838</pub-id><pub-id pub-id-type="pmid">21840837</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kauer</surname><given-names>SD</given-names></name><name><surname>Reid</surname><given-names>SC</given-names></name><name><surname>Crooke</surname><given-names>AHD</given-names></name><name><surname>Khor</surname><given-names>A</given-names></name><name><surname>Hearps</surname><given-names>SJC</given-names></name><name><surname>Jorm</surname><given-names>AF</given-names></name><name><surname>Sanci</surname><given-names>L</given-names></name><name><surname>Patton</surname><given-names>G</given-names></name></person-group><article-title>Self-monitoring using mobile phones in the early stages of adolescent depression: Randomized controlled trial</article-title><source>J Med Internet Res</source><year>2012</year><volume>14</volume><fpage>e67</fpage><pub-id pub-id-type="doi">10.2196/jmir.1858</pub-id><pub-id pub-id-type="pmid">22732135</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proudfoot</surname><given-names>J</given-names></name><name><surname>Clarke</surname><given-names>J</given-names></name><name><surname>Birch</surname><given-names>M-R</given-names></name><name><surname>Whitton</surname><given-names>AE</given-names></name><name><surname>Parker</surname><given-names>G</given-names></name><name><surname>Manicavasagar</surname><given-names>V</given-names></name><name><surname>Harrison</surname><given-names>V</given-names></name><name><surname>Christensen</surname><given-names>H</given-names></name><name><surname>Hadzi-Pavlovic</surname><given-names>D</given-names></name></person-group><article-title>Impact of a mobile phone and web program on symptom and functional outcomes for people with mild-to-moderate depression, anxiety and stress: a randomised controlled trial</article-title><source>BMC Psychiatry</source><year>2013</year><volume>13</volume><fpage>312</fpage><pub-id pub-id-type="doi">10.1186/1471-244X-13-312</pub-id><pub-id pub-id-type="pmid">24237617</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>SC</given-names></name><name><surname>Kauer</surname><given-names>SD</given-names></name><name><surname>Khor</surname><given-names>AS</given-names></name><name><surname>Hearps</surname><given-names>SJC</given-names></name><name><surname>Sanci</surname><given-names>LA</given-names></name><name><surname>Kennedy</surname><given-names>AD</given-names></name><name><surname>Patton</surname><given-names>GC</given-names></name></person-group><article-title>Using a mobile phone application in youth mental health &#x02014; an evaluation study</article-title><source>Aust Fam Physician</source><year>2012</year><volume>41</volume><fpage>711</fpage><lpage>714</lpage><pub-id pub-id-type="pmid">22962650</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watts</surname><given-names>S</given-names></name><name><surname>Mackenzie</surname><given-names>A</given-names></name><name><surname>Thomas</surname><given-names>C</given-names></name><name><surname>Griskaitis</surname><given-names>A</given-names></name><name><surname>Mewton</surname><given-names>L</given-names></name><name><surname>Williams</surname><given-names>A</given-names></name><name><surname>Andrews</surname><given-names>G</given-names></name></person-group><article-title>CBT for depression: a pilot RCT comparing mobile phone vs. computer</article-title><source>BMC Psychiatry</source><year>2013</year><volume>13</volume><fpage>49</fpage><pub-id pub-id-type="doi">10.1186/1471-244X-13-49</pub-id><pub-id pub-id-type="pmid">23391304</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anthes</surname><given-names>E</given-names></name></person-group><article-title>Mental health: there&#x02019;s an app for that</article-title><source>Nature</source><year>2016</year><volume>532</volume><fpage>20</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1038/532020a</pub-id><pub-id pub-id-type="pmid">27078548</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haeffel</surname><given-names>GJ</given-names></name><name><surname>Grigorenko</surname><given-names>EL</given-names></name></person-group><article-title>Cognitive vulnerability to depression: exploring risk and resilience</article-title><source>Child Adolesc Psychiatr Clin N Am</source><year>2007</year><volume>16</volume><fpage>435</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1016/j.chc.2006.11.005</pub-id><pub-id pub-id-type="pmid">17349517</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alloy</surname><given-names>LB</given-names></name><name><surname>Abramson</surname><given-names>LY</given-names></name><name><surname>Whitehouse</surname><given-names>WG</given-names></name><name><surname>Hogan</surname><given-names>ME</given-names></name><name><surname>Panzarella</surname><given-names>C</given-names></name><name><surname>Rose</surname><given-names>DT</given-names></name></person-group><article-title>Prospective incidence of first onsets and recurrences of depression in individuals at high and low cognitive risk for depression</article-title><source>J Abnorm Psychol</source><year>2006</year><volume>115</volume><fpage>145</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1037/0021-843X.115.1.145</pub-id><pub-id pub-id-type="pmid">16492105</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mu&#x000f1;oz</surname><given-names>RF</given-names></name><name><surname>Cuijpers</surname><given-names>P</given-names></name><name><surname>Smit</surname><given-names>F</given-names></name><name><surname>Barrera</surname><given-names>AZ</given-names></name><name><surname>Leykin</surname><given-names>Y</given-names></name></person-group><article-title>Prevention of major depression</article-title><source>Annu Rev Clin Psychol</source><year>2010</year><volume>6</volume><fpage>181</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1146/annurev-clinpsy-033109-132040</pub-id><pub-id pub-id-type="pmid">20192789</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakker</surname><given-names>D</given-names></name><name><surname>Kazantzis</surname><given-names>N</given-names></name><name><surname>Rickwood</surname><given-names>D</given-names></name><name><surname>Rickard</surname><given-names>N</given-names></name></person-group><article-title>Mental health smartphone apps: review and evidence-based recommendations for future developments</article-title><source>JMIR Ment Health</source><year>2016</year><volume>3</volume><fpage>e7</fpage><pub-id pub-id-type="doi">10.2196/mental.4984</pub-id><pub-id pub-id-type="pmid">26932350</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dobson</surname><given-names>D</given-names></name><name><surname>Dobson</surname><given-names>KS</given-names></name></person-group><source>Evidence-based practice of cognitive-behavioral therapy</source><year>2009</year><publisher-loc>New York</publisher-loc><publisher-name>Guilford Press</publisher-name></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohde</surname><given-names>P</given-names></name><name><surname>Stice</surname><given-names>E</given-names></name><name><surname>Shaw</surname><given-names>H</given-names></name><name><surname>Bri&#x000e8;re</surname><given-names>FN</given-names></name></person-group><article-title>Indicated cognitive behavioral group depression prevention compared to bibliotherapy and brochure control: acute effects of an effectiveness trial with adolescents</article-title><source>J Consult Clin Psychol</source><year>2014</year><volume>82</volume><fpage>65</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1037/a0034640</pub-id><pub-id pub-id-type="pmid">24099432</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>H</given-names></name><name><surname>Griffiths</surname><given-names>KM</given-names></name><name><surname>Farrer</surname><given-names>L</given-names></name></person-group><article-title>Adherence in Internet interventions for anxiety and depression</article-title><source>J Med Internet Res</source><year>2009</year><volume>11</volume><fpage>e13</fpage><pub-id pub-id-type="doi">10.2196/jmir.1194</pub-id><pub-id pub-id-type="pmid">19403466</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaltenthaler</surname><given-names>E</given-names></name><name><surname>Parry</surname><given-names>G</given-names></name><name><surname>Beverley</surname><given-names>C</given-names></name><name><surname>Ferriter</surname><given-names>M</given-names></name></person-group><article-title>Computerised cognitive-behavioural therapy for depression: systematic review</article-title><source>Br J Psychiatry J Ment Sci</source><year>2008</year><volume>193</volume><fpage>181</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1192/bjp.bp.106.025981</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>So</surname><given-names>M</given-names></name><name><surname>Yamaguchi</surname><given-names>S</given-names></name><name><surname>Hashimoto</surname><given-names>S</given-names></name><name><surname>Sado</surname><given-names>M</given-names></name><name><surname>Furukawa</surname><given-names>TA</given-names></name><name><surname>McCrone</surname><given-names>P</given-names></name></person-group><article-title>Is computerised CBT really helpful for adult depression? A meta-analytic re-evaluation of CCBT for adult depression in terms of clinical implementation and methodological validity</article-title><source>BMC Psychiatry</source><year>2013</year><volume>13</volume><fpage>113</fpage><pub-id pub-id-type="doi">10.1186/1471-244X-13-113</pub-id><pub-id pub-id-type="pmid">23587347</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>G</given-names></name><name><surname>Cuijpers</surname><given-names>P</given-names></name><name><surname>Craske</surname><given-names>MG</given-names></name><name><surname>McEvoy</surname><given-names>P</given-names></name><name><surname>Titov</surname><given-names>N</given-names></name></person-group><article-title>Computer therapy for the anxiety and depressive disorders is effective, acceptable and practical health care: a meta-analysis</article-title><source>PLoS ONE</source><year>2010</year><volume>5</volume><fpage>e13196</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0013196</pub-id><pub-id pub-id-type="pmid">20967242</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>T</given-names></name><name><surname>Stallard</surname><given-names>P</given-names></name><name><surname>Velleman</surname><given-names>S</given-names></name></person-group><article-title>Computerised cognitive behavioural therapy for the prevention and treatment of depression and anxiety in children and adolescents: a systematic review</article-title><source>Clin Child Fam Psychol Rev</source><year>2010</year><volume>13</volume><fpage>275</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1007/s10567-010-0069-9</pub-id><pub-id pub-id-type="pmid">20532980</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dryden</surname><given-names>W</given-names></name><name><surname>DiGiuseppe</surname><given-names>R</given-names></name></person-group><source>A primer on rational-emotive therapy</source><year>1990</year><publisher-loc>Champaign</publisher-loc><publisher-name>Research Press</publisher-name></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ellis</surname><given-names>A</given-names></name><name><surname>Dryden</surname><given-names>W</given-names></name><name><surname>DiGiuseppe</surname><given-names>R</given-names></name></person-group><source>The practice of rational emotive behavior therapy</source><year>2007</year><publisher-loc>New York</publisher-loc><publisher-name>Springer Publishing Company</publisher-name></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname><given-names>KF</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Moher</surname><given-names>D</given-names></name><collab>for the CONSORT Group</collab></person-group><article-title>CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials</article-title><source>BMJ</source><year>2010</year><volume>340</volume><fpage>c332</fpage><pub-id pub-id-type="doi">10.1136/bmj.c332</pub-id><pub-id pub-id-type="pmid">20332509</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>A-W</given-names></name><name><surname>Tetzlaff</surname><given-names>JM</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Laupacis</surname><given-names>A</given-names></name><name><surname>G&#x000f8;tzsche</surname><given-names>PC</given-names></name><name><surname>Krle&#x0017e;a-Jeri&#x00107;</surname><given-names>K</given-names></name><name><surname>Hr&#x000f3;bjartsson</surname><given-names>A</given-names></name><name><surname>Mann</surname><given-names>H</given-names></name><name><surname>Dickersin</surname><given-names>K</given-names></name><name><surname>Berlin</surname><given-names>JA</given-names></name><name><surname>Dor&#x000e9;</surname><given-names>CJ</given-names></name><name><surname>Parulekar</surname><given-names>WR</given-names></name><name><surname>Summerskill</surname><given-names>WSM</given-names></name><name><surname>Groves</surname><given-names>T</given-names></name><name><surname>Schulz</surname><given-names>KF</given-names></name><name><surname>Sox</surname><given-names>HC</given-names></name><name><surname>Rockhold</surname><given-names>FW</given-names></name><name><surname>Rennie</surname><given-names>D</given-names></name><name><surname>Moher</surname><given-names>D</given-names></name></person-group><article-title>SPIRIT 2013 statement: defining standard protocol items for clinical trials</article-title><source>Ann Intern Med</source><year>2013</year><volume>158</volume><fpage>200</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-158-3-201302050-00583</pub-id><pub-id pub-id-type="pmid">23295957</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crutzen</surname><given-names>R</given-names></name><name><surname>De Nooijer</surname><given-names>J</given-names></name><name><surname>Brouwer</surname><given-names>W</given-names></name><name><surname>Oenema</surname><given-names>A</given-names></name><name><surname>Brug</surname><given-names>J</given-names></name><name><surname>De Vries</surname><given-names>NK</given-names></name></person-group><article-title>A conceptual framework for understanding and improving adolescents&#x02019; exposure to Internet-delivered interventions</article-title><source>Health Promot Int</source><year>2009</year><volume>24</volume><fpage>277</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1093/heapro/dap018</pub-id><pub-id pub-id-type="pmid">19515716</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritterband</surname><given-names>LM</given-names></name><name><surname>Thorndike</surname><given-names>FP</given-names></name><name><surname>Cox</surname><given-names>DJ</given-names></name><name><surname>Kovatchev</surname><given-names>BP</given-names></name><name><surname>Gonder-Frederick</surname><given-names>LA</given-names></name></person-group><article-title>A behavior change model for Internet interventions</article-title><source>Ann Behav Med</source><year>2009</year><volume>38</volume><fpage>18</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1007/s12160-009-9133-4</pub-id><pub-id pub-id-type="pmid">19802647</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Zichermann</surname><given-names>G</given-names></name><name><surname>Cunningham</surname><given-names>C</given-names></name></person-group><source>Gamification by design: implementing game mechanics in web and mobile apps</source><year>2011</year><publisher-loc>Sebastopol</publisher-loc><publisher-name>O&#x02019;Reilly Media</publisher-name></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ellis</surname><given-names>A</given-names></name></person-group><source>Reason and emotion in psychotherapy</source><year>1994</year><publisher-loc>Secaucus</publisher-loc><publisher-name>Carol Publishing Group</publisher-name></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>First</surname><given-names>MB</given-names></name><name><surname>Spitzer</surname><given-names>RL</given-names></name><name><surname>Williams</surname><given-names>JBW</given-names></name><name><surname>Gibbon</surname><given-names>M</given-names></name></person-group><source>Structured Clinical Interview for DSM-IV (SCID)</source><year>1997</year><publisher-loc>Washington, DC</publisher-loc><publisher-name>American Psychological Association</publisher-name></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroenke</surname><given-names>K</given-names></name><name><surname>Spitzer</surname><given-names>RL</given-names></name><name><surname>Williams</surname><given-names>JB</given-names></name></person-group><article-title>The PHQ-9: Validity of a brief depression severity measure</article-title><source>J Gen Intern Med</source><year>2001</year><volume>16</volume><fpage>606</fpage><lpage>613</lpage><pub-id pub-id-type="doi">10.1046/j.1525-1497.2001.016009606.x</pub-id><pub-id pub-id-type="pmid">11556941</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>First</surname><given-names>MB</given-names></name><name><surname>Spitzer</surname><given-names>RB</given-names></name><name><surname>Gibbon</surname><given-names>M</given-names></name><name><surname>Williams</surname><given-names>JBW</given-names></name></person-group><source>Interviu Clinic Structurat Pentru Tulburarile Clinice de Pe Axa 1 a DSM &#x02014; Versiune Clinica</source><year>2007</year><publisher-loc>Cluj-Napoca</publisher-loc><publisher-name>Romanian Psychological Testing Services</publisher-name></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>American Psychiatric Association</collab></person-group><source>Diagnostic and statistical manual of mental disorders</source><year>2000</year><edition>4</edition><publisher-loc>Arlington</publisher-loc><publisher-name>American Psychiatric Pub</publisher-name></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Eaton</surname><given-names>W</given-names></name><name><surname>Muntaner</surname><given-names>C</given-names></name><name><surname>Smith</surname><given-names>C</given-names></name><name><surname>Tien</surname><given-names>A</given-names></name><name><surname>Ybarra</surname><given-names>M</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Maruish</surname><given-names>M</given-names></name></person-group><article-title>Center for Epidemiologic Studies Depression Scale: Review and revision (CESD and CESD-R)</article-title><source>The use of psychological testing for treatment planning and outcomes assessment</source><year>2004</year><edition>3</edition><publisher-loc>Mahwah</publisher-loc><publisher-name>Lawrence Erlbaum</publisher-name><fpage>363</fpage><lpage>374</lpage></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radloff</surname><given-names>LS</given-names></name></person-group><article-title>The CES-D Scale: a self-report depression scale for research in the general population</article-title><source>Appl Psychol Meas</source><year>1977</year><volume>1</volume><fpage>385</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1177/014662167700100306</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Dam</surname><given-names>NT</given-names></name><name><surname>Earleywine</surname><given-names>M</given-names></name></person-group><article-title>Validation of the Center for Epidemiologic Studies Depression Scale&#x02014;Revised (CESD-R): pragmatic depression assessment in the general population</article-title><source>Psychiatry Res</source><year>2011</year><volume>186</volume><fpage>128</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1016/j.psychres.2010.08.018</pub-id><pub-id pub-id-type="pmid">20843557</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>D</given-names></name><name><surname>Clark</surname><given-names>LA</given-names></name><name><surname>Tellegen</surname><given-names>A</given-names></name></person-group><article-title>Development and validation of brief measures of positive and negative affect: the PANAS scales</article-title><source>J Pers Soc Psychol</source><year>1988</year><volume>54</volume><fpage>1063</fpage><lpage>1070</lpage><pub-id pub-id-type="doi">10.1037/0022-3514.54.6.1063</pub-id><pub-id pub-id-type="pmid">3397865</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cristea</surname><given-names>IA</given-names></name><name><surname>Matu</surname><given-names>S</given-names></name><name><surname>Szentagotai T&#x00103;tar</surname><given-names>A</given-names></name><name><surname>David</surname><given-names>D</given-names></name></person-group><article-title>The other side of rumination: reflective pondering as a strategy for regulating emotions in social situations</article-title><source>Anxiety Stress Coping</source><year>2013</year><volume>26</volume><fpage>584</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1080/10615806.2012.725469</pub-id><pub-id pub-id-type="pmid">23009346</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>EL</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>L-Q</given-names></name><name><surname>Ispas</surname><given-names>D</given-names></name><name><surname>Pitariu</surname><given-names>HD</given-names></name><name><surname>Bian</surname><given-names>R</given-names></name><name><surname>Ding</surname><given-names>D</given-names></name><name><surname>Capotescu</surname><given-names>R</given-names></name><name><surname>Che</surname><given-names>H</given-names></name><name><surname>Musat</surname><given-names>S</given-names></name></person-group><article-title>Cross-national explorations of the impact of affect at work using the State-Trait Emotion Measure: a coordinated series of studies in the United States, China, and Romania</article-title><source>Hum Perform</source><year>2011</year><volume>24</volume><fpage>405</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1080/08959285.2011.614302</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diener</surname><given-names>E</given-names></name><name><surname>Emmons</surname><given-names>RA</given-names></name><name><surname>Larsen</surname><given-names>RJ</given-names></name><name><surname>Griffin</surname><given-names>S</given-names></name></person-group><article-title>The Satisfaction With Life Scale</article-title><source>J Pers Assess</source><year>1985</year><volume>49</volume><fpage>71</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1207/s15327752jpa4901_13</pub-id><pub-id pub-id-type="pmid">16367493</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavot</surname><given-names>W</given-names></name><name><surname>Diener</surname><given-names>E</given-names></name><name><surname>Colvin</surname><given-names>CR</given-names></name><name><surname>Sandvik</surname><given-names>E</given-names></name></person-group><article-title>Further validation of the Satisfaction with Life Scale: evidence for the cross-method convergence of well-being measures</article-title><source>J Pers Assess</source><year>1991</year><volume>57</volume><fpage>149</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1207/s15327752jpa5701_17</pub-id><pub-id pub-id-type="pmid">1920028</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavot</surname><given-names>W</given-names></name><name><surname>Diener</surname><given-names>E</given-names></name></person-group><article-title>Review of the Satisfaction With Life Scale</article-title><source>Psychol Assess</source><year>1993</year><volume>5</volume><fpage>164</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1037/1040-3590.5.2.164</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><mixed-citation publication-type="other">Weissman AN, Beck AT: Development and validation of the Dysfunctional Attitude Scale: a preliminary investigation. Paper presented at the 62<sup>nd</sup> Annual Meeting of the American Educational Research Association, Toronto, Ontario, Canada, March 27&#x02013;31, 1978.</mixed-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Graaf</surname><given-names>LE</given-names></name><name><surname>Roelofs</surname><given-names>J</given-names></name><name><surname>Huibers</surname><given-names>MJH</given-names></name></person-group><article-title>Measuring dysfunctional attitudes in the general population: The Dysfunctional Attitude Scale (form A) Revised</article-title><source>Cogn Ther Res</source><year>2009</year><volume>33</volume><fpage>345</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1007/s10608-009-9229-y</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malouff</surname><given-names>JM</given-names></name><name><surname>Schutte</surname><given-names>NS</given-names></name></person-group><article-title>Development and validation of a measure of irrational belief</article-title><source>J Consult Clin Psychol</source><year>1986</year><volume>54</volume><fpage>860</fpage><lpage>862</lpage><pub-id pub-id-type="doi">10.1037/0022-006X.54.6.860</pub-id><pub-id pub-id-type="pmid">3794034</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malouff</surname><given-names>JM</given-names></name><name><surname>Valdenegro</surname><given-names>J</given-names></name><name><surname>Schutte</surname><given-names>NS</given-names></name></person-group><article-title>Further validation of a measure of irrational belief</article-title><source>J Ration Emotive Ther</source><year>1987</year><volume>5</volume><fpage>189</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1007/BF01080527</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollon</surname><given-names>SD</given-names></name><name><surname>Kendall</surname><given-names>PC</given-names></name></person-group><article-title>Cognitive self-statements in depression: development of an automatic thoughts questionnaire</article-title><source>Cogn Ther Res</source><year>1980</year><volume>4</volume><fpage>383</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1007/BF01178214</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrell</surname><given-names>TH</given-names></name><name><surname>Ryon</surname><given-names>NB</given-names></name></person-group><article-title>Cognitive-behavioral assessment of depression: clinical validation of the automatic thoughts questionnaire</article-title><source>J Consult Clin Psychol</source><year>1983</year><volume>51</volume><fpage>721</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.1037/0022-006X.51.5.721</pub-id><pub-id pub-id-type="pmid">6630686</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>David</surname><given-names>D</given-names></name></person-group><source>Scale de Evaluare Clinic&#x00103;</source><year>2007</year><publisher-loc>Cluj Napoca</publisher-loc><publisher-name>Romanian Psychological Testing Services</publisher-name></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moldovan</surname><given-names>R</given-names></name><name><surname>Cobeanu</surname><given-names>O</given-names></name><name><surname>David</surname><given-names>D</given-names></name></person-group><article-title>Cognitive bibliotherapy for mild depressive symptomatology: randomized clinical trial of efficacy and mechanisms of change</article-title><source>Clin Psychol Psychother</source><year>2013</year><volume>20</volume><fpage>482</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1002/cpp.1814</pub-id><pub-id pub-id-type="pmid">22941790</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>V&#x000ee;sl&#x00103;</surname><given-names>A</given-names></name><name><surname>Cristea</surname><given-names>IA</given-names></name><name><surname>Szent&#x000e1;gotai T&#x00103;tar</surname><given-names>A</given-names></name><name><surname>David</surname><given-names>D</given-names></name></person-group><article-title>Core beliefs, automatic thoughts and response expectancies in predicting public speaking anxiety</article-title><source>Personal Individ Differ</source><year>2013</year><volume>55</volume><fpage>856</fpage><lpage>859</lpage><pub-id pub-id-type="doi">10.1016/j.paid.2013.06.003</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanter</surname><given-names>JW</given-names></name><name><surname>Mulick</surname><given-names>PS</given-names></name><name><surname>Busch</surname><given-names>AM</given-names></name><name><surname>Berlin</surname><given-names>KS</given-names></name><name><surname>Martell</surname><given-names>CR</given-names></name></person-group><article-title>The Behavioral Activation for Depression Scale (BADS): psychometric properties and factor structure</article-title><source>J Psychopatol Behav Assess</source><year>2007</year><volume>29</volume><fpage>191</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1007/s10862-006-9038-5</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manos</surname><given-names>RC</given-names></name><name><surname>Kanter</surname><given-names>JW</given-names></name><name><surname>Luo</surname><given-names>W</given-names></name></person-group><article-title>The Behavioral Activation for Depression Scale-Short Form: development and validation</article-title><source>Behav Ther</source><year>2011</year><volume>42</volume><fpage>726</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1016/j.beth.2011.04.004</pub-id><pub-id pub-id-type="pmid">22036000</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><mixed-citation publication-type="other">BineDispus Study - official webpage. <ext-link ext-link-type="uri" xlink:href="http://binedispus.ro/">http://binedispus.ro</ext-link>.</mixed-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billingham</surname><given-names>SA</given-names></name><name><surname>Whitehead</surname><given-names>AL</given-names></name><name><surname>Julious</surname><given-names>SA</given-names></name></person-group><article-title>An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom Clinical Research Network database</article-title><source>BMC Med Res Methodol</source><year>2013</year><volume>13</volume><fpage>104</fpage><pub-id pub-id-type="doi">10.1186/1471-2288-13-104</pub-id><pub-id pub-id-type="pmid">23961782</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ly</surname><given-names>KH</given-names></name><name><surname>Topooco</surname><given-names>N</given-names></name><name><surname>Cederlund</surname><given-names>H</given-names></name><name><surname>Wallin</surname><given-names>A</given-names></name><name><surname>Bergstr&#x000f6;m</surname><given-names>J</given-names></name><name><surname>Molander</surname><given-names>O</given-names></name><name><surname>Carlbring</surname><given-names>P</given-names></name><name><surname>Andersson</surname><given-names>G</given-names></name></person-group><article-title>Smartphone-supported versus full behavioural activation for depression: a randomised controlled trial</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><fpage>e0126559</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0126559</pub-id><pub-id pub-id-type="pmid">26010890</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><mixed-citation publication-type="other">Project Dcombat: A Computerized Preventative and Therapeutic Intervention for Depression. <ext-link ext-link-type="uri" xlink:href="http://dcombat.net/en/">http://dcombat.net/en/</ext-link>.</mixed-citation></ref><ref id="CR83"><label>83.</label><mixed-citation publication-type="other">CDC. Burden of mental illness - mental illness - mental health basics - mental health. 2013. <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/mentalhealth/basics/burden.htm">http://www.cdc.gov/mentalhealth/basics/burden.htm</ext-link>.&#x000a0;Accessed 14 Apr 2016.</mixed-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>RC</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Blazer</surname><given-names>DG</given-names></name><name><surname>Swartz</surname><given-names>M</given-names></name></person-group><article-title>Prevalence, correlates, and course of minor depression and major depression in the national comorbidity survey</article-title><source>J Affect Disord</source><year>1997</year><volume>45</volume><fpage>19</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/S0165-0327(97)00056-6</pub-id><pub-id pub-id-type="pmid">9268772</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preisig</surname><given-names>M</given-names></name><name><surname>Merikangas</surname><given-names>KR</given-names></name><name><surname>Angst</surname><given-names>J</given-names></name></person-group><article-title>Clinical significance and comorbidity of subthreshold depression and anxiety in the community</article-title><source>Acta Psychiatr Scand</source><year>2001</year><volume>104</volume><fpage>96</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1034/j.1600-0447.2001.00284.x</pub-id><pub-id pub-id-type="pmid">11473502</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rapaport</surname><given-names>MH</given-names></name><name><surname>Judd</surname><given-names>LL</given-names></name><name><surname>Schettler</surname><given-names>PJ</given-names></name><name><surname>Yonkers</surname><given-names>KA</given-names></name><name><surname>Thase</surname><given-names>ME</given-names></name><name><surname>Kupfer</surname><given-names>DJ</given-names></name><name><surname>Frank</surname><given-names>E</given-names></name><name><surname>Plewes</surname><given-names>JM</given-names></name><name><surname>Tollefson</surname><given-names>GD</given-names></name><name><surname>Rush</surname><given-names>AJ</given-names></name></person-group><article-title>A descriptive analysis of minor depression</article-title><source>Am J Psychiatry</source><year>2002</year><volume>159</volume><fpage>637</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.159.4.637</pub-id><pub-id pub-id-type="pmid">11925303</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ed;guez</surname><given-names>MR</given-names></name><name><surname>Nuevo</surname><given-names>R</given-names></name><name><surname>Chatterji</surname><given-names>S</given-names></name><name><surname>Ayuso-Mateos</surname><given-names>JL</given-names></name></person-group><article-title>Definitions and factors associated with subthreshold depressive conditions: a systematic review</article-title><source>BMC Psychiatry</source><year>2012</year><volume>12</volume><fpage>181</fpage><pub-id pub-id-type="doi">10.1186/1471-244X-12-181</pub-id><pub-id pub-id-type="pmid">23110575</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fergusson</surname><given-names>DM</given-names></name><name><surname>Horwood</surname><given-names>LJ</given-names></name><name><surname>Ridder</surname><given-names>EM</given-names></name><name><surname>Beautrais</surname><given-names>AL</given-names></name></person-group><article-title>Subthreshold depression in adolescence and mental health outcomes in adulthood</article-title><source>Arch Gen Psychiatry</source><year>2005</year><volume>62</volume><fpage>66</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1001/archpsyc.62.1.66</pub-id><pub-id pub-id-type="pmid">15630074</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trivedi</surname><given-names>MH</given-names></name><name><surname>Rush</surname><given-names>AJ</given-names></name><name><surname>Wisniewski</surname><given-names>SR</given-names></name><name><surname>Nierenberg</surname><given-names>AA</given-names></name><name><surname>Warden</surname><given-names>D</given-names></name><name><surname>Ritz</surname><given-names>L</given-names></name><name><surname>Norquist</surname><given-names>G</given-names></name><name><surname>Howland</surname><given-names>RH</given-names></name><name><surname>Lebowitz</surname><given-names>B</given-names></name><name><surname>McGrath</surname><given-names>PJ</given-names></name><name><surname>Shores-Wilson</surname><given-names>K</given-names></name><name><surname>Biggs</surname><given-names>MM</given-names></name><name><surname>Balasubramani</surname><given-names>GK</given-names></name><name><surname>Fava</surname><given-names>M</given-names></name><collab>STAR*D Study Team</collab></person-group><article-title>Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice</article-title><source>Am J Psychiatry</source><year>2006</year><volume>163</volume><fpage>28</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.163.1.28</pub-id><pub-id pub-id-type="pmid">16390886</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donker</surname><given-names>T</given-names></name><name><surname>Petrie</surname><given-names>K</given-names></name><name><surname>Proudfoot</surname><given-names>J</given-names></name><name><surname>Clarke</surname><given-names>J</given-names></name><name><surname>Birch</surname><given-names>M-R</given-names></name><name><surname>Christensen</surname><given-names>H</given-names></name></person-group><article-title>Smartphones for smarter delivery of mental health programs: a systematic review</article-title><source>J Med Internet Res</source><year>2013</year><volume>15</volume><issue>11</issue><fpage>e247</fpage><pub-id pub-id-type="doi">10.2196/jmir.2791</pub-id><pub-id pub-id-type="pmid">24240579</pub-id></element-citation></ref></ref-list></back></article>